| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |